📈 Jumpstart Signal Watchlist — July 16, 2026

🏢 What they do: Bioventus Inc. is a global medical device company that develops and commercializes clinically proven, minimally invasive products to relieve pain and address musculoskeletal challenges by enhancing the body's natural healing process .
- 🎯 Current $12.43 is 9% below 3yr high $13.71 · ⏳ SMA200 $8.47 (current price $12.43 is above) · 💰 Market Cap $836M
- BVS shows decent technicals supported by positive sentiment.

💎 Quality (Q): 43/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 200% (>20%); ROE 15% (>15%); Near-high ROE setup (52wk high + ROE); PEG ratio 0.15 (<1.5).
⏰ Entry (E): 6/20
- 🔔 Strong above EMA21 (14.2%)
- 🔔 Strong above EMA50 (22.4%)
- 🔔 SMA20/SMA50 bullish crossover
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 69 showing strength
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive.
✅ Bioventus (NASDAQ:BVS) Reaches New 12-Month High - Here's Why — MarketBeat.
🤖 The stock hit a new 12-month high driven by positive Wall Street sentiment, multiple buy/outperform reiterations, and a consensus price target of $14.75, which is significantly above the current trading price.
✅ Hillsdale Investment Management Inc. Raises Stake in ... — MarketBeat.
🤖 Hillsdale Investment Management increased its stake in Bioventus, signaling institutional confidence, while analysts maintain a consensus 'Buy' rating with an average price target of $14.75.
✅ Bioventus shares rise after Medicare reverses reimbursement cuts — Investing.com.
🤖 Bioventus shares climbed up to 13% after the Centers for Medicare & Medicaid Services reversed previously issued reimbursement cuts for the company's non-invasive bone growth stimulators, directly improving revenue potential.
🍭 Bonus (B): 0/10 — Surgical & Medical Instruments

🏢 What they do: Flywire Corporation is a global payments enablement and software company that helps businesses collect and reconcile payments, especially for complex, cross-border transactions. Its platform includes invoice-to-cash automation, payment collection, currency conversion, and ERP/accounting reconciliation for industries like education, healthcare, travel, and B2B.
- 🎯 Current $18.69 is 47% below 3yr high $35.05 · ⏳ SMA200 $13.92 (current price $18.69 is above) · 💰 Market Cap $2.3B
- FLYW passed all filters and shows favorable conditions.

💎 Quality (Q): 48/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 433% (>20%); Revenue growth 41% (>15%); Low LT D/E 0.02 (<1.0); PEG ratio 0.18 (<1.5).
⏰ Entry (E): 2/20
- 🔔 Strong above EMA21 (7.0%)
- 🔔 Strong above EMA50 (14.6%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 63 showing strength
📢 Sentiment (S): 5/10
- 🗞️ News sentiment is neutral (mixed coverage).
✅ Atlassian, Sprout Social, and Flywire Stocks Trade Up, What You Need To Know — Yahoo Finance.
🤖 Flywire jumped 5.1% and set a new 52-week high at $18.82, with the stock up 35.4% since the beginning of the year, indicating strong recent momentum and investor interest.
❌ Chief Payments Officer Sells 54,000 Flywire Shares for $827,000 — The Motley Fool.
🤖 Chief Payments Officer Mohit Kansal sold 54,000 shares for $827,000 in an open-market transaction per SEC Form 4, which can signal reduced insider confidence or personal liquidity needs, potentially weighing on sentiment.
🍭 Bonus (B): 0/10 — Business Services

🏢 What they do: Ooma, Inc. provides cloud-based VoIP phone systems and unified communications services for businesses and consumers, featuring voice, messaging, video, and AI tools like call transcriptions and answering services. Their primary offerings include Ooma Office for small to mid-sized businesses, Ooma AirDial for POTS line replacement, and Ooma Telo for affordable residential landline service.
- 🎯 At/above 3yr high $20.83 (current $20.83) · ⏳ SMA200 $13.97 (current price $20.83 is above) · 💰 Market Cap $571M
- OOMA shows decent technicals supported by positive sentiment.

💎 Quality (Q): 54/60
- 🏦 Low drawdown (14.2% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 1000% (>20%); Revenue growth 25% (>15%); Low LT D/E 0.50 (<1.0).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA21 (7.3%)
- 🔔 Strong above EMA50 (13.8%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 66 showing strength
📢 Sentiment (S): 8/10
- 🗞️ News sentiment is positive.
✅ Ooma, Inc. (NYSE:OOMA) Receives Consensus Recommendation of Moderate Buy from Brokerages — MarketBeat.
🤖 Ooma received a "Moderate Buy" consensus from six firms (four Buys, two Holds) with an average 12-month price target of $22.33, signaling analyst confidence and potential upside from the current price near $20.82[1].
✅ Hsbc Holdings PLC Buys 50114 Shares of Ooma, Inc. $OOMA — MarketBeat.
🤖 HSBC Holdings PLC purchased 50,114 shares of Ooma, reflecting institutional buying interest alongside the stock's "Moderate Buy" consensus rating and $22.33 average price target[2].
⚪️ Ooma CEO Eric Stang sells $464240 of Ooma stock — Investing.com.
🤖 While CEO Eric Stang sold $464,240 worth of stock, the article emphasizes that Ooma recently beat Q1 FY2027 earnings and revenue expectations, raised its outlook, and saw analysts like Freedom Broker and Benchmark raise price targets to $20 and $24 respectively[4].
⚪️ Ooma (NYSE:OOMA) CEO Sells 23212 Shares of Stock — MarketBeat.
🤖 The CEO sold 23,212 shares, but the report notes the sale occurred alongside constructive results including beating quarterly EPS and revenue estimates and maintaining a "Moderate Buy" rating with a $22.33 consensus target[15].
🍭 Bonus (B): 10/10 — Computer Processing & Data Prep (Technology sector)

🏢 What they do: Spectrum Brands Holdings, Inc. is a consumer products company that makes and markets home essentials for everyday use, including appliances, pet care products, lawn and garden products, and pest-control items. Its brands include products such as Remington, Russell Hobbs, FURminator, Tetra, Cutter, and Spectracide.
- 🎯 Current $89.60 is 7% below 3yr high $95.89 · ⏳ SMA200 $69.55 (current price $89.60 is above) · 💰 Market Cap $4.8B
- SPB shows decent technicals supported by positive sentiment.

💎 Quality (Q): 51/60
- 🏦 Base breakout (range: 8.6%); Low drawdown (14.5% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 3033% (>20%); Low LT D/E 0.26 (<1.0).
⏰ Entry (E): 7/20
- 🔔 Strong above EMA21 (6.1%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 65 showing strength
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive.
✅ Spectrum Brands stock hits 52-week high at $88.21 — Investing.com.
🤖 The stock reached a 52-week high of $88.21 after Spectrum Brands reported second-quarter fiscal 2026 financial results that exceeded analysts' expectations, signaling strong operational performance.
🍭 Bonus (B): 0/10 — Misc Electrical Machinery

🏢 What they do: Concentra Group Holdings Parent, Inc. is a provider of occupational health services in the United States, focused on helping employers manage workplace injuries and employee health. Its services include occupational health centers, onsite employer clinics, telemedicine, workers’ compensation care, and other direct-to-employer health services.
- 🎯 Current $31.64 is 1% below 3yr high $31.91 · ⏳ SMA200 $22.77 (current price $31.64 is above) · 💰 Market Cap $4.0B
- CON shows decent technicals supported by positive sentiment.

💎 Quality (Q): 56/60
- 🏦 Low drawdown (13.6% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 30% (>20%); ROE 42% (>15%); Low LT D/E 0.00 (<1.0).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA21 (5.0%)
- 🔔 Strong above EMA50 (13.2%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 70 showing strength
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive.
✅ Concentra Standout in Occupational Medicine: Analyst - Concentra Group Holdings (NYSE:CON) — Benzinga.
🤖 The article highlights that CON shares hit a new 52-week high and rose 3.26% to $30.72, signaling strong market momentum and analyst confidence in the company's position in occupational medicine[3].
✅ William Blair startet Coverage für Concentra mit 'Outperform' — Investing.com.
🤖 William Blair initiated coverage on Concentra with an 'Outperform' rating, noting the stock has surged 60% from its 52-week low, while Goldman Sachs also added a buy recommendation with a $30 price target[1].
✅ וויליאם בלייר פותח כיסוי על מנית סטוק של Concentra עם דירוג ביצוע עודף — Investing.com.
🤖 William Blair initiated coverage with an 'Outperform' rating following Concentra's strong Q1 2026 earnings ($0.40 EPS, $569.6M revenue), which prompted Truist and Mizuho to raise their price targets to $31 and $30 respectively[2].
🍭 Bonus (B): 0/10 — Specialty Outpatient Facilities

🏢 What they do: John Wiley & Sons, Inc. (Wiley) is a global research and learning company that publishes over 1,900 peer-reviewed scientific, technical, medical, and scholarly journals along with academic and professional books, encyclopedias, and digital content .
- 🎯 Current $50.94 is 4% below 3yr high $53.13 · ⏳ SMA200 $37.39 (current price $50.94 is above) · 💰 Market Cap $2.7B
- WLY shows decent technicals supported by positive sentiment.

💎 Quality (Q): 56/60
- 🏦 Low drawdown (8.9% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 103% (>20%); ROE 26% (>15%); Low LT D/E 0.81 (<1.0).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA50 (11.7%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 63 showing strength
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive.
✅ The Bull Case For John Wiley & Sons (WLY) Could ... — Yahoo Finance.
🤖 The article highlights a Board-approved quarterly dividend of $0.3575 per share and reports strong Q4 sales of $447.94 million with full-year net income of $221.62 million, signaling robust financial health and shareholder returns.
✅ Wiley Raises Dividend for 33rd Consecutive Year, Powered by Research and AI Momentum, Record Margins, and Strong Cash Flow — Business Wire.
🤖 Wiley declared a 33rd consecutive annual dividend increase to $0.3575 per share, driven by record margins, strong cash flow, and momentum in research and AI, which are key positive indicators for stock valuation.
✅ John Wiley & Sons A stock hits 52-week high at 45.88 USD — Investing.com.
🤖 The stock reached a 52-week high with a 48.58% year-to-date gain, while the company reported Q4 2026 adjusted EPS of $1.67 that beat Wall Street estimates of $1.55, despite a slight revenue miss.
🍭 Bonus (B): 0/10 — Book Publishing

🏢 What they do: American Healthcare REIT, Inc. (NYSE: AHR) is a real estate investment trust that acquires, owns, and operates a diversified portfolio of clinical healthcare properties, focusing primarily on senior housing communities, skilled nursing facilities, and outpatient medical buildings across the United States, the United Kingdom, and the Isle of Man.
- 🎯 At/above 3yr high $56.59 (current $56.59) · ⏳ SMA200 $48.46 (current price $56.59 is above) · 💰 Market Cap $10.7B
- AHR shows decent technicals supported by positive sentiment.

💎 Quality (Q): 55/60
- 🏦 Low drawdown (14.1% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 425% (>20%); Revenue growth 23% (>15%); Low LT D/E 0.00 (<1.0).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA21 (7.3%)
- 🔔 Strong above EMA50 (10.6%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 70 showing strength
📢 Sentiment (S): 9/10
- 🗞️ News sentiment is positive.
✅ American Healthcare REIT, Inc. $AHR Shares Purchased by Bi Capital AG — MarketBeat.
🤖 Bi Capital AG purchased shares of $AHR, signaling institutional confidence; the stock holds a 'Moderate Buy' consensus rating with a $56.00 price target, supporting upward price momentum.
✅ Barclays initiates American Healthcare REIT stock at Overweight — Investing.com.
🤖 Barclays initiated coverage with an 'Overweight' rating and a $61.00 price target, well above the current ~$53.83 trading price, while other analysts like KeyBanc and Citizens also raised targets or reiterated strong ratings.
⚪️ American Healthcare REIT (AHR) Stock Price, News & Analysis — MarketBeat.
🤖 The article reports $AHR closed at $56.60 on July 16, 2026, up 4.46%, but provides no new company-specific developments, analyst opinions, or financial data beyond standard price movement.
🍭 Bonus (B): 0/10 — REITs